CHUK and adenocarcinoma: When maintained in vivo as tumor xenografts in immune-compromised NSG mice for 3 wk, each of the three IKKα deficient human NSCLC lines presented significantly greater adenocarcinoma tumor burdens than their IKKαWT controls.